MRK · Merck & Co Inc
United States · RS rating 95 · As of 2026-10-14
| Price | 147.37 USD |
|---|---|
| 1-day change | +3.8% |
| RS rating (overall / 1M / 3M / 12M) | 95 / 83 / 89 / 93 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 47 / 57 / 35 |
| Industry group (rank) | Medical-Ethical Drugs (91) |
| EPS growth Q/Q | -48.7% |
| Sales growth Q/Q | -5.1% |
| Distance from 52-week high | +5.8% |
| Market cap (USD) | $283.1B |